Related references
Note: Only part of the references are listed.Activation profiles and regulatory cascades of the human kallikrein-related peptidases
Hyesook Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Multiple sclerosis: Is there neurodegeneration independent from inflammation?
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Distribution of 15 human kallikreins in tissues and biological fluids
Julie L. V. Shaw et al.
CLINICAL CHEMISTRY (2007)
Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects
Mami Noda et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
The autolytic regulation of human kallikrein-related peptidase 6
Sachiko I. Blaber et al.
BIOCHEMISTRY (2007)
Potential scope of action of tissue kallikreins in CNS immune-mediated disease
I. A. Scarisbrick et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
Å Lundwall et al.
BIOLOGICAL CHEMISTRY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis
CF Xia et al.
HUMAN GENE THERAPY (2006)
Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis
R Terayama et al.
GLIA (2005)
Expression of myelencephalon-specific protease in transient middle cerebral artery occlusion model of rat brain
A Uchida et al.
MOLECULAR BRAIN RESEARCH (2004)
Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease
GP Christophi et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury
F Hellal et al.
JOURNAL OF NEUROTRAUMA (2003)
Mouse mast cells express the tryptic protease neuropsin/Prss19
GW Wong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma
EP Diamandis et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Dose effects of growth hormone during puberty
P Saenger
HORMONE RESEARCH (2003)
Crystal structure and biochemical characterization of human kallikrein 6 reveals that a trypsin-like kallikrein is expressed in the central nervous system
MJ Bernett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activity of a newly identified serine protease in CNS demyelination
IA Scarisbrick et al.
BRAIN (2002)
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients
M Zarghooni et al.
CLINICAL BIOCHEMISTRY (2002)
Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death
C Lesuisse et al.
JOURNAL OF NEUROBIOLOGY (2002)
Enzymatic properties of rat myelencephalon-specific protease
SI Blaber et al.
BIOCHEMISTRY (2002)
Kallikrein and kinin receptor expression in inflammation and cancer
K Bhoola et al.
BIOLOGICAL CHEMISTRY (2001)
Altered neutrophil homeostasis in kinin B1 receptor-deficient mice
RC Araujo et al.
BIOLOGICAL CHEMISTRY (2001)
Detection of tissue kallikrein and kinn B1 and B2 receptor mRNAs in human brain by in situ RT-PCR
R Mahabeer et al.
METABOLIC BRAIN DISEASE (2000)
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4
TJ Harvey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Human kallikrein 6 as a biomarker of Alzheimer's disease
EP Diamandis et al.
CLINICAL BIOCHEMISTRY (2000)
Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region
L Gan et al.
GENE (2000)
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4
GM Yousef et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)